8.65
price down icon0.35%   -0.03
after-market アフターアワーズ: 8.69 0.04 +0.46%
loading
前日終値:
$8.68
開ける:
$8.44
24時間の取引高:
317.81K
Relative Volume:
0.90
時価総額:
$455.20M
収益:
-
当期純損益:
$-197.68M
株価収益率:
-1.5175
EPS:
-5.7
ネットキャッシュフロー:
$-158.88M
1週間 パフォーマンス:
+2.13%
1か月 パフォーマンス:
+49.40%
6か月 パフォーマンス:
+243.25%
1年 パフォーマンス:
+210.04%
1日の値動き範囲:
Value
$8.33
$8.95
1週間の範囲:
Value
$8.03
$9.55
52週間の値動き範囲:
Value
$2.185
$11.60

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
名前
Kodiak Sciences Inc
Name
セクター
Healthcare (1176)
Name
電話
650-281-0850
Name
住所
1200 PAGE MILL RD, PALO ALTO, CA
Name
職員
108
Name
Twitter
@kodiaksciences
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
KOD's Discussions on Twitter

KOD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KOD
Kodiak Sciences Inc
8.65 455.20M 0 -197.68M -158.88M -3.76
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-09 アップグレード Jefferies Hold → Buy
2024-09-05 開始されました H.C. Wainwright Neutral
2023-12-11 再開されました Goldman Sell
2023-11-17 アップグレード CapitalOne Equal Weight → Overweight
2023-07-27 ダウングレード UBS Buy → Neutral
2023-07-25 ダウングレード Chardan Capital Markets Buy → Neutral
2023-07-25 ダウングレード JP Morgan Neutral → Underweight
2023-07-24 ダウングレード CapitalOne Overweight → Equal Weight
2023-07-24 ダウングレード Jefferies Buy → Hold
2022-11-15 開始されました CapitalOne Overweight
2022-08-02 ダウングレード Citigroup Neutral → Sell
2022-02-24 ダウングレード JP Morgan Overweight → Neutral
2022-02-11 開始されました Goldman Buy
2022-02-02 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード ROTH Capital Neutral → Buy
2021-03-12 開始されました Evercore ISI Outperform
2021-03-01 ダウングレード Barclays Equal Weight → Underweight
2021-02-17 ダウングレード ROTH Capital Buy → Neutral
2021-01-25 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-12-17 開始されました Berenberg Buy
2020-12-16 開始されました UBS Buy
2020-12-11 開始されました Citigroup Neutral
2020-11-30 ダウングレード JP Morgan Overweight → Neutral
2020-11-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-11-13 ダウングレード Goldman Buy → Neutral
2020-03-31 開始されました BMO Capital Markets Outperform
2020-03-03 開始されました Goldman Buy
2020-02-18 ダウングレード Barclays Overweight → Equal Weight
2020-02-06 開始されました SunTrust Buy
2020-01-08 開始されました ROTH Capital Buy
2020-01-03 開始されました Jefferies Buy
2019-12-24 開始されました JP Morgan Overweight
2019-10-15 繰り返されました Chardan Capital Markets Buy
2019-02-20 開始されました Chardan Capital Markets Buy
2018-10-29 開始されました Barclays Overweight
2018-10-29 開始されました BofA/Merrill Buy
2018-10-29 開始されました Morgan Stanley Overweight
すべてを表示

Kodiak Sciences Inc (KOD) 最新ニュース

pulisher
Dec 19, 2024

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Bought by Fmr LLC - Defense World

Dec 19, 2024
pulisher
Dec 15, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com South Africa

Dec 15, 2024
pulisher
Dec 15, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India

Dec 15, 2024
pulisher
Dec 15, 2024

Critical Survey: Allogene Therapeutics (NASDAQ:ALLO) versus Kodiak Sciences (NASDAQ:KOD) - Defense World

Dec 15, 2024
pulisher
Dec 13, 2024

Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 13, 2024

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Simply Wall St

Dec 13, 2024
pulisher
Dec 10, 2024

KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential - MSN

Dec 10, 2024
pulisher
Dec 10, 2024

Nona Biosciences Partners With Kodiak Sciences For Ophthalmic Antibody Discovery - Contract Pharma

Dec 10, 2024
pulisher
Dec 10, 2024

Nona Biosciences and Kodiak Sciences Inc. Partners on Next-Generation Antibody Therapies for Ophthalmic Diseases - Marketscreener.com

Dec 10, 2024
pulisher
Dec 10, 2024

Nona Biosciences, Kodiak Sciences partner on antibody therapies for ophthalmic diseases - Seeking Alpha

Dec 10, 2024
pulisher
Dec 09, 2024

Kodiak Sciences Partners with Nona Biosciences for Novel Eye Disease Antibody Development - StockTitan

Dec 09, 2024
pulisher
Dec 09, 2024

Jefferies Upgrades Kodiak Sciences (KOD) - MSN

Dec 09, 2024
pulisher
Dec 09, 2024

Kodiak stock rallies 32% after Jefferies upgrades to buy - MSN

Dec 09, 2024
pulisher
Dec 09, 2024

Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 09, 2024
pulisher
Dec 09, 2024

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock - Yahoo Finance

Dec 09, 2024
pulisher
Dec 09, 2024

Kodiak Sciences shares initiated with buy rating on positive outlook By Investing.com - Investing.com South Africa

Dec 09, 2024
pulisher
Dec 09, 2024

Kodiak stock rallies 32% after Jefferies upgrades to buy (NASDAQ:KOD) - Seeking Alpha

Dec 09, 2024
pulisher
Dec 09, 2024

Kodiak Sciences shares initiated with buy rating on positive outlook - Investing.com

Dec 09, 2024
pulisher
Dec 09, 2024

Kodiak Sciences (NASDAQ:KOD) Upgraded to "Buy" at Jefferies Financial Group - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Jacobs Levy Equity Management Inc. Sells 118,375 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat

Dec 09, 2024
pulisher
Dec 07, 2024

Kodiak Sciences stock hits 52-week high at $7.81 By Investing.com - Investing.com Canada

Dec 07, 2024
pulisher
Dec 06, 2024

Kodiak Sciences stock hits 52-week high at $7.81 - Investing.com India

Dec 06, 2024
pulisher
Nov 25, 2024

Kodiak Sciences Inc. (KOD) Just Flashed Golden Cross Signal: Do You Buy? - MSN

Nov 25, 2024
pulisher
Nov 21, 2024

Kodiak Sciences' SWOT analysis: biotech firm's stock faces pivotal trials - Investing.com

Nov 21, 2024
pulisher
Nov 20, 2024

Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

GSA Capital Partners LLP Makes New Investment in Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Kodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade) - Seeking Alpha

Nov 15, 2024
pulisher
Nov 15, 2024

Kodiak Sciences (NASDAQ:KOD) Given New $4.00 Price Target at Barclays - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Kodiak Sciences Inc (KOD) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Kodiak Sciences: Drug Shows 3x Longer Half-Life, Reports $43.9M Q3 Loss | KOD Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 11, 2024

Diabetic Retinopathy Clinical Trials 2024: FDA Approvals, - openPR

Nov 11, 2024
pulisher
Nov 11, 2024

Kodiak Sciences to Present at Two Major Healthcare Investor Conferences | KOD Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Report Finds Big Disparities in Americans' Well-Being by Region - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Bystanders More Readily Perform CPR If 911 Operator Instructs - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

How ADHD May Influence a Child's Weight - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 07, 2024

Empowering Growth: Diabetic Macular Edema Market 2024 - openPR

Nov 07, 2024
pulisher
Nov 06, 2024

Age-Related Macular Degeneration Market Size in the 7MM is expected to Grow by 2034, estimates DelveInsight - Barchart

Nov 06, 2024
pulisher
Nov 01, 2024

Bow-legged girl 14 cm taller after life-changing surgery - 69News WFMZ-TV

Nov 01, 2024
pulisher
Nov 01, 2024

Kodiak Sciences (KOD) Price Target Increased by 25.00% to 5.10 - MSN

Nov 01, 2024
pulisher
Oct 25, 2024

Zacks Research Raises Earnings Estimates for Kodiak Sciences - MarketBeat

Oct 25, 2024
pulisher
Oct 22, 2024

Age-related Macular Degeneration Market Size is Set for Rapid - openPR

Oct 22, 2024
pulisher
Oct 22, 2024

Sanctuary Advisors LLC Purchases New Holdings in Denny’s Co. (NASDAQ:DENN) - Defense World

Oct 22, 2024

Kodiak Sciences Inc (KOD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Kodiak Sciences Inc (KOD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BORGESON JOHN A.
See Remarks
Jun 12 '24
Sale
2.92
1,558
4,549
179,544
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):